Medical/Pharmaceuticals

DEBIOPHARM REINFORCES THE BOND BETWEEN SWISS AND JAPANESE CANCER RESEARCH WITH THE 2022 JCA MAUVERNAY AWARD CEREMONY

Debiopharm awards the winning scientists for the JCA (Japanese Cancer Association) Award for innovative, disruptive, and translational oncology research  LAUSANNE, Switzerland, Oct. 3, 2022 /PRNewswire/ -- Debiopharm ( www.debiopharm.com ), a Swiss-based global bioph...

2022-10-03 15:00 2449

AeroRx Partners with HCmed to Develop a Nebulized LABA/LAMA Combination Solution for the Treatment of Chronic Obstructive Pulmonary Disease

TAIPEI, Oct. 2, 2022 /PRNewswire/ -- AeroRx Therapeutics, LLC. (AeroRx) and HCmed Innovations Co., Ltd. (HCmed) have initiated a collaboration, introducing a LABA/LAMA combination solution for delivery with a breath-actuated nebulizer. This collaboration sets forth the framework by which both com...

2022-10-03 09:00 2185

Qilian International Holding Group Limited Reports Financial Results for the First Six Months of Fiscal Year 2022

JIUQUAN, China, Sept. 30, 2022 /PRNewswire/ -- Qilian International Holding Group Limited (Nasdaq: QLI) (the "Company"), aChina-based pharmaceutical and chemical products manufacturer, today announced its unaudited financial results for the first six months of fiscal year 2022 endedMarch 31, 2022...

2022-10-01 04:30 5760

Concord Medical Announces Changes in Management

BEIJING, Sept. 30, 2022 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers and cancer hospitals and operating an extens...

2022-10-01 04:01 3433

Nomination committee has been appointed for Mentice AB (publ) Annual General Meeting 2023

GOTHENBURG, Sweden, Oct.1, 2022 /PRNewswire/ -- Mentice AB (publ) a leading supplier of high-technology solutions for simulation in the medical sector with focus on endovascular procedures, announces that the nomination committee for the company's Annual General Meeting 2023 has been appointed. ...

2022-10-01 00:53 3188

Infinitus Products Received the Hong Kong Q-Mark Certificate

GUANGZHOU, China, Sept. 30, 2022 /PRNewswire/ -- The Q-Mark 43rd Anniversary cum Presentation Ceremony has been successfully held at the Hong Kong Convention and Exhibition Centre on2 September 2022. Nine Infinitus Products Have Received the Hong Kong Q-Mark Product Certification.

2022-09-30 19:23 3341

YS BIOPHARMA TO MERGE WITH NASDAQ-LISTED SUMMIT HEALTHCARE ACQUISITION CORP.

* Transaction values YS Biopharma at pre-money equity value of $834 million * Certain investors ("Forward Purchase Investors") are expected to invest $30 million in a private placement concurrently with the closing of the business combination transaction pursuant to certain forward purchase ag...

2022-09-30 04:01 3311

First Patient in New Zealand Dosed with Illuccix® - Telix's Prostate Cancer Imaging Agent

MELBOURNE, Australia, Sept. 30, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces the first commercial dose inNew Zealand of its prostate cancer imaging agent, Illuccix® (Kit for Preparation of Ga-68 Glu-urea-Lys(ahx)-hbed-CC Injection), also known ...

2022-09-30 02:30 3505

Doxy.me extends telemedicine's reach to 88% of the world's population

Doxy.me adds over 100 languages, live interpreters, and global currencies to overcome barriers to telemedicine around the world. CHARLESTON, S.C., Sept. 30, 2022 /PRNewswire/ -- Doxy.me, the web-based telemedicine platform on a mission to make telemedicine available to all, is expanding its capa...

2022-09-29 22:03 2593

XSENSOR Earns the Frost & Sullivan 2022 Technology Innovation Leadership Award for Intelligent Dynamic Sensing Systems

Delivers innovative pressure measurement solutions to the world's most demanding customers. SAN ANTONIO, Sept. 29, 2022 /PRNewswire/ -- Based on its recent analysis of the sensor technology in the medical devices market,Frost & Sullivan recognizes XSENSOR Technology Corporation with the 2022 Nor...

2022-09-29 21:00 1846

Samsung Biologics introduces new development platforms S-DUAL™ and DEVELOPICK™ at BPI Boston 2022

* Two distinctive platforms will streamline the antibody development process. * With an advanced design and high binding affinity, S-DUAL™ ensures optimized manufacturability of bispecific antibodies. * DEVELOPICK™ provides early insight and selection guidance to save time and cost to maxi...

2022-09-29 19:00 2246

NeuShen Therapeutics Closes Pre-A Financing with ~$20M

* Closure of pre-A financing round led by LAMPAM Capital * Dual internal discovery platforms of small molecule and AAV-based gene therapy targeting neurological and psychiatric disorders SHANGHAI, Sept. 29, 2022 /PRNewswire/ -- NeuShen Therapeutics, Inc., a biotechnology company focusing on d...

2022-09-29 17:50 2707

'Generations Connect' Project Brings Young People Together with the Elderly to Boost Emotional Resilience

Engaging tailored e-platform and healthcare students promote the wellbeing of the elderly HONG KONG, Sept. 29, 2022 /PRNewswire/ -- In recent years due to the COVID-19 pandemic, elderly people have had to stay mostly at home. Confined to small living spaces for prolonged periods, many senior cit...

2022-09-29 17:37 4568

Kintor Pharma Announces Publication of Phase Ib Data from Pruxelutamide for AR+ mBC in EJC

SUZHOU, China, Sept. 29, 2022 /PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, today announced that the results from a phase Ib study of pruxelutamide (used to be ...

2022-09-29 14:22 2208

Manulife Hong Kong research reveals attitude shift on how Hongkongers live with COVID-19

* Hong Kong residents are trying to regain normalcy in daily lives * Mental and physical health in decline * Majority of respondents concerned about spread of another unknown disease in Hong Kong HONG KONG, Sept. 29, 2022 /PRNewswire/ -- Manulife Hong Kong today announced the results of its h...

2022-09-29 13:13 4378

Simcere and Almirall Enter into a Licensing Agreement for IL-2 mu-Fc

* Simcere will receive a $15 million upfront payment, and up to $492 million in development and commercial milestone payments considering successful achievements in several indications, with an important part as sales milestones, as well as up to low double-digit tiered royalties based upon fu...

2022-09-29 11:32 2602

Green Mountain Biotech and Kamedis Announce First Patent in China for Unique Herb-Based Acne and Skin Relief Solution

Clinically-tested solution, based on a proprietary blend of six herbs used in Traditional Chinese Medicine, helps relieve symptoms of acne and other skin inflammation conditions. TEL AVIV, Israel, Sept. 29, 2022 /PRNewswire/ -- Green Mountain Biotech (GMB), the ...

2022-09-29 09:00 3805

Green Mountain Biotech and Kamedis Announce First Patent in China for Unique Herb-Based Acne and Skin Relief Solution

Clinically-tested solution, based on a proprietary blend of six herbs used in Traditional Chinese Medicine, helps relieve symptoms of acne and other skin inflammation conditions. TEL AVIV, Israel, Sept. 29, 2022 /PRNewswire/ -- Green Mountain Biotech (GMB), the ...

2022-09-29 09:00 2343

GC Labs becomes the first Korean laboratory to obtain certification of CDC standardization programs (VDSCP & HoSt)

YONGIN, South Korea and AUSTIN, Texas, Sept. 28, 2022 /PRNewswire/ -- GC Labs, a leadingSouth Korea clinical laboratory, today announced that it has recently obtained certification of standardization programs from the U.S. Centers for Disease Control and Prevention (CDC) for vitamin D and hormone...

2022-09-29 08:17 1968

CLIMATE CHANGE AND HEALTH INEQUITY A DEADLY MIX FOR THE MOST VULNERABLE: WORLD HEART FEDERATION

GENEVA, Sept. 29, 2022 /PRNewswire/ -- On World Heart Day, the World Heart Federation (WHF) is calling for urgent action on climate change and health inequity, saying millions more lives are now at risk from cardiovascular disease, which is still the world's biggest killer. Climate change and ai...

2022-09-29 06:01 3331
1 ... 519520521522523524525 ... 643